|
02.10.2018 12:28:54
|
Vistin Pharma ASA : Prospectus Summary for transfer of listing from Oslo Axess to Oslo Børs
Oslo, Norway, 2 October 2018
Reference is made to the announcement on 26 September 2018 regarding Oslo Børs' resolution to admit the shares in Vistin Pharma ASA to listing on Oslo Børs.
Vistin Pharma ASA today published a Prospectus Summary pursuant to section 7-2 of the Securities Trading Regulation in connection with the Company's transfer of listing from Oslo Axess to Oslo Børs.
Please find the Prospectus Summary attached. The Prospectus Summary will also be made available on www.vistin.com.
*****
For further information, please contact:
Gunnar Manum
CFO
+47 95 17 91 90
gunnar.manum@vistin.com
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
This announcement is distributed by West Corporation on behalf of West Corporation clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Vistin Pharma ASA via Globenewswire
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Vistin Pharma ASA via Globenewswire
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Vistin Pharma ASAmehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu Vistin Pharma ASAmehr Analysen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.